Future of specialty pharmacy and patient access previewed at Asembia Summit 2022
Summary
We left this conference with a lot of steps taken (it was half a mile from my hotel room to the networking breakfast) and with a new sense of optimism for hospital specialty pharmacies leading the way to better outcomes and patient experience. Hospital pharmacies have done an outstanding job of working with their provider groups to make prior authorizations successful and help patients with discounts and assistance programs. The dialogue started off with a clever title that perhaps brought happiness to many attendees—340B and “the impending cliff.” It was more of a debate about why manufacturers are making unilateral changes to 340B and the bigger question of whether it will continue through the next decade. The current approach will be short lived, what with the forthcoming new administrative dispute resolution process and lobbying efforts by all parties to solve the problem, which ultimately will lead only to negative public relations for manufacturers. Discussions around technology solutions, from patient monitoring programs to robotics, and about supporting compliance in high-cost drug markets, drew great interest from attendees.
Classifications
AskAI Classifications
LabelsLinked Companies
